Cited by 565Alcohol Consumption and Health EffectsGenetic Associations and EpidemiologyLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

Open access

Buch, Stephan, Stickel, Felix, Trépo, Eric, Way, Michael, Herrmann, Alexander, Nischalke, Hans Dieter, Brosch, Mario, Rosendahl, Jonas, Berg, Thomas, Ridinger, Monika, Rietschel, Marcella, McQuillin, Andrew, Frank, Josef, Kiefer, Falk, Schreiber, Stefan, Lieb, Wolfgang, Soyka, Michael, Semmo, Nasser, Aigner, Elmar, Datz, Christian, Schmelz, Renate, Brückner, Stefan, Zeissig, Sebastian, Stephan, Anna-Magdalena, Wodarz, Norbert, Devière, Jacques, Clumeck, Nicolas, Sarrazin, Christoph, Lammert, Frank, Gustot, Thierry, Deltenre, Pierre, Völzke, Henry, Lerch, Markus M, Mayerle, Julia, Eyer, Florian, Schafmayer, Clemens, Cichon, Sven, Nöthen, Markus M, Nothnagel, Michael, Ellinghaus, David, Huse, Klaus, Franke, Andre, Zopf, Steffen, Hellerbrand, Claus, Moreno, Christophe, Franchimont, Denis, Morgan, Marsha Y, Hampe, Jochen·2015·Nature Genetics

DOI 10.1038/ng.3417

Open this paper in CoChat — free account Open PDF

Abstract

Alcohol misuse is the leading cause of cirrhosis and the second most common indication for liver transplantation in the Western world. We performed a genome-wide association study for alcohol-related cirrhosis in individuals of European descent (712 cases and 1,426 controls) with subsequent validation in two independent European cohorts (1,148 cases and 922 controls). We identified variants in the MBOAT7 (P = 1.03 × 10(-9)) and TM6SF2 (P = 7.89 × 10(-10)) genes as new risk loci and confirmed rs738409 in PNPLA3 as an important risk locus for alcohol-related cirrhosis (P = 1.54 × 10(-48)) at a genome-wide level of significance. These three loci have a role in lipid processing, suggesting that lipid turnover is important in the pathogenesis of alcohol-related cirrhosis.

Integrity signals

Registry

Crossref · 10.1038/ng.3417

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies
Howie, B. N., Donnelly, P., & Marchini, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000529 · Cited by 3,928
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
LocusZoom: regional visualization of genome-wide association scan results
Pruim, R. J., Welch, R. P., Sanna, S., Teslovich, T. M., Chines, P. S., Gliedt, T. P., Boehnke, M., Abecasis, G. R., & Willer, C. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq419 · Cited by 2,707
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
study, F. T. D., Daly, A. K., Donaldson, P. T., Bhatnagar, P., Shen, Y., Pe’er, I., Floratos, A., Daly, M. J., Goldstein, D. B., John, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.379 · Cited by 1,051
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits
Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Global burden of alcoholic liver diseases
Rehm, J., Samokhvalov, A. V., & Shield, K. D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.007 · Cited by 740

Show all 49 references

Research works printed but not linked: 1

Treutlein, J. et al. Genome-wide association study of alcohol dependence. Arch. Gen. Psychiatry 66, 773–784 (2009). · DOI

Sorted by citations

Items 101–200 of 563

MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD
Meroni, M., Longo, M., Fracanzani, A. L., & Dongiovanni, P. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102866 · Cited by 92
MBOAT7 Down-Regulation by Hyperinsulinemia Induces Fat Accumulation in Hepatocytes
Meroni, M., Dongiovanni, P., Longo, M., Carli, F., Baselli, G., Rametta, R., Pelusi, S., Badiali, S., Maggioni, M., Gaggini, M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2020.102658 · Cited by 84
The membrane‐bound O‐acyltransferase domain‐containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B
Thabet, K., Chan, H. L., Petta, S., Mangia, A., Berg, T., Boonstra, A., Brouwer, W. P., Abate, M. L., Wong, V. W., Nazmy, M., et al. (2017) · Hepatology · doi:10.1002/hep.29064 · Cited by 86
Self-citation
Does pressure cause liver cirrhosis? The sinusoidal pressure hypothesis
Mueller, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10482 · Cited by 89
Therapeutic opportunities for the treatment of NASH with genetically validated targets
Lindén, D., & Romeo, S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.05.007 · Cited by 86
PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease
Dong, X. C. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00304 · Cited by 88
PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases
Monroy-Ramírez, H. C., Galicia‐Moreno, M., Sandoval-Rodriguez, A. S., Meza-Ríos, A., Santos, A., & Armendáriz‐Borunda, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158298 · Cited by 86
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers
Whitfield, J. B., Schwantes-An, T.-H. L., Darlay, R., Aithal, G. P., Atkinson, S. R., Bataller, R. A., Botwin, G., Chalasani, N., Cordell, H. J., Daly, A. K., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.10.005 · Cited by 90
Self-citation
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
Costanzo, A. D., Belardinilli, F., Bailetti, D., Sponziello, M., D’Erasmo, L., Polimeni, L., Baratta, F., Pastori, D., Ceci, F., Montali, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21939-0 · Cited by 86
Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis
Nahon, P., Bamba‐Funck, J., Layese, R., Trépo, E., Zucman‐Rossi, J., Cagnot, C., Ganne‐Carrié, N., Chaffaut, C., Guyot, E., Ziol, M., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.11.003 · Cited by 84
Self-citation
Targeting cell-intrinsic metabolism for antifibrotic therapy
Gilgenkrantz, H., Mallat, A., Moreau, R., & Lotersztajn, S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.012 · Cited by 76
High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase–Lowering Effect of a HSD17B13 Variant
Gellert‐Kristensen, H., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Stender, S. (2019) · Hepatology · doi:10.1002/hep.30799 · Cited by 83
Nonalcoholic fatty liver disease stratification by liver lipidomics
Vvedenskaya, O., Rose, T. D., Knittelfelder, O. L., Palladini, A., Wodke, J. A. H., Schuhmann, K., Ackerman, J. M., Wang, Y., Has, C., Brosch, M., et al. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100104 · Cited by 84
Self-citation
Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update
Sookoian, S. C., Rotman, Y., & Valenti, L. V. C. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.05.052 · Cited by 88
Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)
Choudhary, N. S., & Duseja, A. K. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.09.06 · Cited by 84
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1
Innes, H. A., Buch, S., Hutchinson, S. J., Guha, I. N., Morling, J. R., Barnes, E. J., Irving, W. L., Forrest, E. H., Pedergnana, V., Goldberg, D. J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.014 · Cited by 79
Self-citation
Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease
Fengler, V. H., Macheiner, T., Kessler, S. M., Czepukojc, B., Gemperlein, K., Müller, R., Kiemer, A. K., Magnes, C., Haybaeck, J., Lackner, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155163 · Cited by 78
PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery
Krawczyk, M. J., Jiménez-Agüero, R., Alústiza, J. M., Emparanza, J. I., Perugorria, M. J., Bujanda, L., Lammert, F., & Bañales, J. M. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.06.004 · Cited by 75
Self-citation
Key Events Participating in the Pathogenesis of Alcoholic Liver Disease
Magdaleno, F., Blajszczak, C. C., & Nieto, N. (2017) · Biomolecules · doi:10.3390/biom7010009 · Cited by 75
Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis
Ghouse, J., Sveinbjörnsson, G., Vujković, M., Seidelin, A.-S., Gellert‐Kristensen, H., Ahlberg, G., Tragante, V., Rand, S. A., Brancale, J., Vilarinho, S., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01720-y · Cited by 79
Hepatocellular Carcinoma: A Comprehensive Review
Amin, N. A., Anwar, J., Sulaiman, A. A., Naumova, N., & Anwar, N. (2025) · Diseases · doi:10.3390/diseases13070207 · Cited by 82
Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease
Raya Tonetti, F., Eguileor, A., Mrdjen, M., Pathak, V., Travers, J., Nagy, L. E., & Llorente, C. (2024) · Hepatology · doi:10.1097/hep.0000000000000924 · Cited by 78
Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease
Wang, Z., Zhu, S., Jia, Y., Wang, Y., Kubota, N., Fujiwara, N., Gordillo, R., Lewis, C., Zhu, M., Sharma, T., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.014 · Cited by 72
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials
Armisen, J., Rauschecker, M., Sarv, J., Liljeblad, M., Wernevik, L. C., Niazi, M., Knöchel, J., Eklund, O., Sandell, T., Sherwood, J. L., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.12.046 · Cited by 75
Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics
Sookoian, S. C., & Pirola, C. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1679920 · Cited by 78
Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases
Tabassum, R., & Ripatti, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03715-4 · Cited by 76
Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches
Dongiovanni, P., Paolini, E., Corsini, A., Sirtori, C. R., & Ruscica, M. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13519 · Cited by 73
Dynamic human liver proteome atlas reveals functional insights into disease pathways
Niu, L., Geyer, P. E., Gupta, R., Santos, A., Meier, F., Doll, S., Albrechtsen, N. J. W., Klein, S., Ortiz, C., Uschner, F. E., et al. (2022) · Molecular Systems Biology · doi:10.15252/msb.202210947 · Cited by 67
Proximity proteomics reveals a mechanism of fatty acid transfer at lipid droplet-mitochondria- endoplasmic reticulum contact sites
Bezawork‐Geleta, A., Devereux, C. J., Keenan, S. N., Lou, J., Cho, H., Nie, S., Souza, D. P. D., Narayana, V. K., Siddall, N. A., Rodrigues, C. H. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57405-5 · Cited by 72
Genetic Insights for Drug Development in NAFLD
Eslam, M., & George, J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.05.002 · Cited by 68
Combined alcoholic and non-alcoholic steatohepatitis
Wandji, L. C. N., Gnemmi, V., Mathurin, P., & Louvet, A. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100101 · Cited by 70
Non-alcoholic Fatty Liver Disease, Metabolic syndrome, and Type 2 diabetes mellitus: Where do we stand today?
Mitrovic, B., Obradovic, M. M., Gluvic, Z. M., Radunovic, M. L., Rizzo, M., Banach, M., & Isenović, E. R. (2022) · Archives of Medical Science · doi:10.5114/aoms/150639 · Cited by 84
Hepatic Fat—Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs
Degasperi, E., Galmozzi, E., Pelusi, S., D’Ambrosio, R., Soffredini, R., Borghi, M., Perbellini, R., Facchetti, F., Iavarone, M. A., Sangiovanni, A., et al. (2020) · Hepatology · doi:10.1002/hep.31500 · Cited by 67
Genetics Is of the Essence to Face NAFLD
Meroni, M., Longo, M., Tria, G., & Dongiovanni, P. (2021) · Biomedicines · doi:10.3390/biomedicines9101359 · Cited by 69
Macrophages in metabolic associated fatty liver disease
Alharthi, J., Latchoumanin, O., George, J., & Eslam, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i16.1861 · Cited by 65
Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis
Atkinson, S. R., Way, M. J., McQuillin, A., Morgan, M. Y., & Thursz, M. R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.018 · Cited by 66
Self-citation
How is the acyl chain composition of phosphoinositides created and does it matter?
Barneda, D., Cosulich, S., Stephens, L., & Hawkins, P. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190205 · Cited by 65
Effects of Age, Sex, Body Weight, and Quantity of Alcohol Consumption on Occurrence and Severity of Alcoholic Hepatitis
Liangpunsakul, S., Puri, P., Shah, V. H., Kamath, P. S., Sanyal, A. J., Urban, T. J., Ren, X., Katz, B. P., Radaeva, S., Chalasani, N., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.05.041 · Cited by 64
17‐Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury
Ma, Y., Brown, P. M., Lin, D. D., Ma, J., Feng, D., Belyaeva, O. V., Podszun, M. C., Roszik, J., Allen, J. N., Umarova, R., et al. (2020) · Hepatology · doi:10.1002/hep.31517 · Cited by 64
Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
Staufer, K., & Stauber, R. E. (2023) · Biomedicines · doi:10.3390/biomedicines11082108 · Cited by 63
Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride
Stender, S., Šmagris, Ē., Lauridsen, B. K., Kofoed, K. F., Nordestgaard, B. G., Tybjærg‐Hansen, A., Pennacchio, L. A., Dickel, D. E., Cohen, J. C., & Hobbs, H. H. (2017) · Hepatology · doi:10.1002/hep.29751 · Cited by 61
NAFLD-Associated HCC: Progress and Opportunities
Geh, D., Anstee, Q. M., & Reeves, H. L. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s272213 · Cited by 64
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Thiele, M. S., Villesen, I. F., Niu, L., Johansen, S., Sulek, K., Nishijima, S., Espen, L. V., Keller, M. I., Israelsen, M. E., Suvitaival, T., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.03.035 · Cited by 67
Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?
Hagström, H. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0343-0 · Cited by 62
Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis
Ehrhardt, N., Doche, M. E., Chen, S., Mao, H. Z., Walsh, M. T., Bedoya, C., Guindi, M. M., Xiong, W., Irudayam, J. I., Iqbal, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx159 · Cited by 60
From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis
Moore, J. B. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119000570 · Cited by 60
Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apoB-100 particles in Finns
Kim, D. S., Jackson, A. U., Li, Y. K., Stringham, H. M., Kuusisto, J., Kangas, A. J., Soininen, P., Ala‐Korpela, M., Burant, C., Salomaa, V. V., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.p076034 · Cited by 60
The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth
Umano, G. R., Caprio, S., Sessa, A. D., Chalasani, N., Dykas, D. J., Pierpont, B. M., Bale, A. E., & Santoro, N. (2018) · The American Journal of Gastroenterology · doi:10.1038/ajg.2018.1 · Cited by 57
Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment
Feng, F., & Zhao, Y. (2024) · Medical Principles and Practice · doi:10.1159/000539349 · Cited by 62
MBOAT7 is anchored to endomembranes by six transmembrane domains
Caddeo, A. M., Jamialahmadi, O., Solinas, G., Pujia, A., Mancina, R. M., Pingitore, P., & Romeo, S. (2019) · Journal of Structural Biology · doi:10.1016/j.jsb.2019.04.006 · Cited by 55
The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives
Pennisi, G., Celsa, C., Giammanco, A., Spatola, F., & Petta, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225613 · Cited by 52
TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis
Basytė-Bacevičė, V., Skiecevičienė, J., Valantienė, I., Šumskienė, J., Petrenkienė, V., Kondrackienė, J., Petrauskas, D., Lammert, F., & Kupčinskas, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061277 · Cited by 54
Self-citation
Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease
Kahali, B., Halligan, B. D., & Speliotes, E. K. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1567870 · Cited by 53
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
Buch, S., Innes, H. A., Lutz, P. L., Nischalke, H. D., Marquardt, J. U., Fischer, J., Weiss, K. H., Rosendahl, J., Marot, A., Krawczyk, M. J., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327196 · Cited by 53
Self-citation
Gene and Network Analysis of Common Variants Reveals Novel Associations in Multiple Complex Diseases
Nakka, P., Raphael, B. J., & Ramachandran, S. (2016) · Genetics · doi:10.1534/genetics.116.188391 · Cited by 55
Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease
Brouwers, M. C. G. J., Simons, N., Stehouwer, C. D. A., Koek, G. H., Schaper, N. C., & Isaacs, A. J. (2019) · Hepatology Communications · doi:10.1002/hep4.1319 · Cited by 53
Genetic variants that associate with cirrhosis have pleiotropic effects on human traits
Chen, V. L., Chen, Y., Du, X., Handelman, S. K., & Speliotes, E. K. (2019) · Liver International · doi:10.1111/liv.14321 · Cited by 54
Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort
Wang, J., Conti, D. V., Bogumil, D. D., Sheng, X., Noureddin, M., Wilkens, L. R., Marchand, L. L., Rosen, H. R., Haiman, C. A., & Setiawan, V. W. (2021) · Hepatology Communications · doi:10.1002/hep4.1751 · Cited by 53
The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C
Manchiero, C., Nunes, A. K. D. S., Magri, M. C., Dantas, B. P., Mazza, C. C., Barone, A. A., & Tengan, F. M. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2887-6 · Cited by 51
Genetic predisposition in metabolic‐dysfunction‐associated fatty liver disease and cardiovascular outcomes—Systematic review
Ismaiel, A., & Dumitrascu, D. L. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13331 · Cited by 51
Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers
Whitfield, J. B., Masson, S., Liangpunsakul, S., Mueller, S., Aithal, G. P., Eyer, F., Gleeson, D. C., Thompson, A., Stickel, F., Soyka, M., et al. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000833 · Cited by 51
Self-citation
Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma
Raksayot, M., Chuaypen, N., Khlaiphuengsin, A., Pinjaroen, N., Treeprasertsuk, S., Poovorawan, Y., Tanaka, Y., & Tangkijvanich, P. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-01533-x · Cited by 51
The role of IFN in the development of NAFLD and NASH
Møhlenberg, M., Terczyńska‐Dyla, E., Thomsen, K. L., George, J., Eslam, M., Grønbæk, H., & Hartmann, R. (2018) · Cytokine · doi:10.1016/j.cyto.2018.08.013 · Cited by 50
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets
Bianco, C., Casirati, E., Malvestiti, F., & Valenti, L. V. C. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100284 · Cited by 51
Epidemiology of Alcohol-Associated Liver Disease
Han, S., Yang, Z., Zhang, T., Ma, J., Chandler, K., & Liangpunsakul, S. (2021) · Clinics in Liver Disease · doi:10.1016/j.cld.2021.03.009 · Cited by 50
Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges
Li, S., Saviano, A., Erstad, D. J., Hoshida, Y., Fuchs, B. C., Baumert, T., & Tanabe, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123817 · Cited by 46
The role of cytochrome P4502E1 in the pathogenesis of alcoholic liver disease and carcinogenesis
Seitz, H. K. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108918 · Cited by 48
Update on genetics and epigenetics in metabolic associated fatty liver disease
Zhu, X., Xia, M., & Gao, X. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221132138 · Cited by 50
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · Biomedicines · doi:10.3390/biomedicines11041166 · Cited by 52
Alcohol-associated liver disease: Natural history, management and novel targeted therapies
Alvarado‐Tápias, E., Pose, E., Gratacós‐Ginès, J., Clemente, A. P. G., López‐Pelayo, H., & Bataller, R. A. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0709 · Cited by 55
Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications
Martin, K., Hatab, A., Athwal, V. S., Jokl, E. J., & Hanley, K. P. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01377-5 · Cited by 46
Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models
Caon, E., Martins, M. C., Hodgetts, H., Blanken, L., Vilia, M. G., Levi, A., Thanapirom, K., Al‐Akkad, W., Abu‐Hanna, J., Baselli, G., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.032 · Cited by 45
Alcohol-associated liver cancer
Fu, Y., Maccioni, L., Wang, X. W., Greten, T. F., & Gao, B. (2024) · Hepatology · doi:10.1097/hep.0000000000000890 · Cited by 50
PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease
Ray, S. B. (2019) · Adipocyte · doi:10.1080/21623945.2019.1607423 · Cited by 50
The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort
Meffert, P. J., Repp, K., Völzke, H., Weiß, F. U., Homuth, G., Kühn, J., Lerch, M. M., & Aghdassi, A. A. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.038 · Cited by 46
Self-citation
Non-alcoholic fatty liver disease: a narrative review of genetics
Christopher, J., Zemin, Y., & Jiang, Z. G. (2018) · Journal of Biomedical Research · doi:10.7555/jbr.32.20180045 · Cited by 46
Contribution of a genetic risk score to ethnic differences in fatty liver disease
Kubiliun, M. J., Cohen, J. C., Hobbs, H. H., & Kozlitina, J. (2022) · Liver International · doi:10.1111/liv.15322 · Cited by 45
Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment
Chen, V. L., Kuppa, A., Oliveri, A., Chen, Y., Ponnandy, P., Patel, P. B., Palmer, N. D., & Speliotes, E. K. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186424 · Cited by 47
The History of Alcoholic Liver Disease: From an Unrecognized Disease to One of the Most Frequent Diseases in Hepatology
Seitz, H. K., & Neuman, M. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040858 · Cited by 45
Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics
Lim, H.-W., & Bernstein, D. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.008 · Cited by 47
A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes
Schneider, C. V., Schneider, K. M., Conlon, D., Park, J., Vujković, M., Zandvakili, I., Ko, Y.-A., Trautwein, C., Carr, R. M., Strnad, P., et al. (2021) · Med · doi:10.1016/j.medj.2021.04.011 · Cited by 44
Sequentially fermented dealcoholized apple juice intervenes fatty liver induced by high-fat diets via modulation of intestinal flora and gene pathways
Li, H., Liang, J., Han, M., Wang, X., Ren, Y., Wang, Y., Huang, J., Li, S., Liu, C., Wang, Z., et al. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111180 · Cited by 47
Liver Diseases in Latin America: Current Status, Unmet Needs, and Opportunities for Improvement
Díaz, L. A., Ayares, G., Arnold, J., Idalsoaga, F. J., Corsi, Ó., Arrese, M. A., & Arab, J. P. (2022) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-022-00382-1 · Cited by 49
Alcohol and the mechanisms of liver disease
Chen, M., Zhong, W., & Xu, W. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16282 · Cited by 43
The contribution of genetics and epigenetics to MAFLD susceptibility
Moretti, V., Romeo, S., & Valenti, L. V. C. (2024) · Hepatology International · doi:10.1007/s12072-024-10667-5 · Cited by 48
MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease
Ruissen, M. M., Mak, A. L., Beuers, U. H., Tushuizen, M. E., & Holleboom, A. G. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0065 · Cited by 45
Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
Ikejima, K., Kon, K., & Yamashina, S. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0202 · Cited by 41
Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma
Gull, N., Arshad, F., Naikoo, G. A., Hassan, I. U., Pedram, M. Z., Ahmad, A., Aljabali, A. A. A., Mishra, V. K., Satija, S., Charbe, N. B., et al. (2022) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-022-00809-z · Cited by 42
Advances in the understanding and management of alcohol-related liver disease
Thursz, M. R., & Lingford-Hughes, A. R. (2023) · BMJ · doi:10.1136/bmj-2023-077090 · Cited by 41
Epigenetics of alcohol-related liver diseases
Habash, N. W., Sehrawat, T. S., Shah, V. H., & Cao, S. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100466 · Cited by 44
Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity
Costanzo, A. D., Pacifico, L., Chiesa, C., Perla, F. M., Ceci, F., Angeloni, A., D’Erasmo, L., Martino, M. D., & Arca, M. (2019) · Pediatric Research · doi:10.1038/s41390-019-0303-1 · Cited by 41
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver diseasePreprint
Emdin, C. A., Haas, M., Khera, A. V., Aragam, K. G., Chaffin, M. D., Jiang, L., Wei, W., Feng, Q., Karjalainen, J. M., Havulinna, A. S., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/594523 · Cited by 40
Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males
Zhang, Y., Guo, T., Yang, F., Mao, Y., Li, L., Liu, C., Sun, Q., Li, Y., & Huang, J. (2018) · Hepatology International · doi:10.1007/s12072-018-9889-3 · Cited by 39
Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility
Xia, Y., Huang, C., Li, G., Chen, K.-H., Li, H., Tang, L., Luo, H., & Bao, M. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.01.008 · Cited by 38
Insights into genetic variants associated with NASH-fibrosis from metabolite profiling
Mann, J. P., Pietzner, M., Wittemans, L. B. L., Rolfe, E. D. L., Kerrison, N. D., Imamura, F., Forouhi, N. G., Fauman, E. B., Allison, M., Griffin, J. L., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa162 · Cited by 39
The burden of liver disease in Latin America
Díaz, L. A., Villota‐Rivas, M., Francisco Barrera, M., Lazarus, J. V., & Arrese, M. A. (2023) · Annals of Hepatology · doi:10.1016/j.aohep.2023.101175 · Cited by 42
MetALD: Does it require a different therapeutic option?
Marek, G. W., & Malhi, H. (2024) · Hepatology · doi:10.1097/hep.0000000000000935 · Cited by 41
Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension
Mandorfer, M., Scheiner, B., Stättermayer, A. F., Schwabl, P., Paternostro, R., Bauer, D. J. M., Schaefer, B., Zoller, H., Peck‐Radosavljevic, M., Trauner, M. A., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14856 · Cited by 37
Genetic and lifestyle risk factors for advanced liver disease among men and women
Sahlman, P., Nissinen, M. J., Puukka, P. J., Jula, A., Salomaa, V. V., Männistö, S., Lundqvist, A., Valsta, L. M., Perola, M., Färkkilä, M. A., et al. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14770 · Cited by 36
The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis
Liu, Z., Que, S., Zhou, L., Zheng, S., Romeo, S., Mardinoğlu, A., & Valenti, L. V. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-09548-9 · Cited by 35

Authors: Buch, S., Stickel, F., Trépo, E., Way, M., Herrmann, A., Nischalke, H. D., Brosch, M., Rosendahl, J., Berg, T., Ridinger, M., Rietschel, M., McQuillin, A., Frank, J., Kiefer, F., Schreiber, S., Lieb, W., Soyka, M., Semmo, N., Aigner, E., Datz, C., Schmelz, R., Brückner, S., Zeissig, S., Stephan, A.-M., Wodarz, N., Devière, J., Clumeck, N., Sarrazin, C., Lammert, F., Gustot, T., Deltenre, P., Völzke, H., Lerch, M. M., Mayerle, J., Eyer, F., Schafmayer, C., Cichon, S., Nöthen, M. M., Nothnagel, M., Ellinghaus, D., Huse, K., Franke, A., Zopf, S., Hellerbrand, C., Moreno, C., Franchimont, D., Morgan, M. Y., & Hampe, J.
Affiliations: University Hospital Carl Gustav Carus (DE)
University Hospital Zurich (CH)
Université Libre de Bruxelles (BE)
The Royal Free Hospital (GB)
University of Bonn (DE)
University Hospital Leipzig (DE)
Kanton Aargau (CH)
Heidelberg University (DE)
University College London (GB)
University Hospital Schleswig-Holstein (DE)
Christian-Albrechts-Universität zu Kiel (DE)
Ludwig-Maximilians-Universität München (DE)
University Hospital of Bern (CH)
University of Salzburg (AT)
University of Regensburg (DE)
University Hospital Frankfurt (DE)
Universitätsklinikum des Saarlandes (DE)
Universitätsmedizin Greifswald (DE)
TUM Klinikum (DE)
University Hospital of Basel (CH)
University of Cologne (DE)
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
Universitätsklinikum Erlangen (DE)
University Hospital Regensburg (DE)
Corresponding author: Stickel, Felix
ORCID: Buch, Stephan
Stickel, Felix
Trépo, Eric
Way, Michael
Herrmann, Alexander
Nischalke, Hans Dieter
Brosch, Mario
Rosendahl, Jonas
Berg, Thomas
Ridinger, Monika
Rietschel, Marcella
McQuillin, Andrew
Frank, Josef
Kiefer, Falk
Schreiber, Stefan
Lieb, Wolfgang
Soyka, Michael
Semmo, Nasser
Aigner, Elmar
Datz, Christian
Schmelz, Renate
Zeissig, Sebastian
Wodarz, Norbert
Lammert, Frank
Gustot, Thierry
Deltenre, Pierre
Völzke, Henry
Lerch, Markus M
Mayerle, Julia
Eyer, Florian
Schafmayer, Clemens
Cichon, Sven
Nöthen, Markus M
Nothnagel, Michael
Ellinghaus, David
Huse, Klaus
Hellerbrand, Claus
Moreno, Christophe
Franchimont, Denis
Morgan, Marsha Y
Hampe, Jochen
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 2015-10-19
Volume: 47
Issue: 12
Pages: 1443-1448
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng.3417
OpenAlex: W1830916533
Cited by: 565
References: 49
Citations by year: 2026: 30 · 2025: 38 · 2024: 51 · 2023: 72 · 2022: 54 · 2021: 69 · 2020: 82 · 2019: 57 · 2018: 44 · 2017: 43 · 2016: 21 · 2015: 2
FWCI: 29.10
Type: journal article
Language: en
Open access: green
www.zora.uzh.ch
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
Bern Open Repository and Information System (University of Bern) (submittedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
IRIS (submittedVersion)
mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
Zurich Open Repository and Archive (University of Zurich)
Funders: National Eye Institute (01EY1103)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: alcoholic cirrhosis, PNPLA3, MBOAT7, TM6SF2, genetic susceptibility loci, rs738409, lipid metabolism, alcohol abuse
MeSH terms: Acyltransferases, Adult, Aged, Female, Humans, Lipase, Liver Cirrhosis, Alcoholic, Male, Membrane Proteins, Middle Aged, Risk Factors, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Phospholipases A2, Calcium-Independent, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks